Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Ross A. Baker - Atypical Antipsychotic Drugs and Diabetes Mellitus in the US Food and Drug Administration Adverse Event Database: A Systematic Bayesian Signal Detection Analysis
1
x
$
30.00
Nitric Oxide, Stress, and Depression
1
x
$
30.00
Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy
1
x
$
30.00
A Pilot Study of the Pharmacodynamic Impact of SSRI Drug Selection and Beta-1 Receptor Genotype (ADRB1) on Cardiac Vital Signs in Depressed Patients: A Novel Pharmacogenetic Approach
1
x
$
30.00
VOL 3 No. 1 Full Issue - January 2001
1
x
$
20.00
A Comprehensive Review and Update of the Use of Dexmedetomidine for Regional Blocks
2
x
$
30.00
Probable Olanzapine-Related Idiopathic Intracranial Hypertension in an Adolescent with First-Episode Psychosis
1
x
$
30.00
Addressing Methodological Issues in Studying Antidepressant Onset Efficacy Using Prespecified Sensitivity Analyses
1
x
$
30.00
Arif Khan, MD: Suicide Risk Analysis Among Patients Assigned to Psychotropics and Placebo
1
x
$
30.00
Unmet Needs in the Treatment of Anxiety Disorders
1
x
$
30.00
Psychopharmacology Bulletin VOL 47 No. 2, 2017 - Full Issue Stacked PDF
1
x
$
60.00
View Cart
Checkout
Home
montgomery-asberg-depression-rating-scale
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Analysis of Symptoms in Patients With Major Depressive Disorder Treated With Desvenlafaxine or Placebo
$
30.00
Add to cart
Details
Depression Rating Scales – A Doctor’s Guide
$
15.00
Add to cart
Details
Page load link
Go to Top
